JAZZ and UTHR Related Headlines
Go Back- Raymond James sees potential for beats across biopharma coverage
- JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
- JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
